Skip to main content
. 2021 Feb 5;2021:6649142. doi: 10.1155/2021/6649142

Table 2.

Liver parameters at baseline and after 6 months of dietary intervention.

Variable Anti-inflammatory diet group (n = 42) Control diet group (n = 39) Baseline p valueb 6 months p valuec
Baseline 6 months Change (%) p valuea Baseline 6 months Change (%) p valuea
AST (IU/L) 21.7 (7.9) 20.7 (6.1) −4.8 0.516 24.0 (6.5) 23.0 (6.4) −4.2 0.885 0.263 0.075
ALT (IU/L) 24.3 (13.5) 22.6 (11.2) −6.8 0.914 31.9 (13.1) 29.3 (14.7) −8.1 0.416 0.540 0.099
GGT (IU/L) 22.43 (9.9) 17.7 (6.7) −21.3 0.011 25.4 (5.6) 21.8 (6.6) −14.3 0.003 0.212 0.040
NAFLD-FLS 0.46 (2.2) −0.2 (2.1) −143.4 0.158 0.0 (0.8) −0.1 (1.4) −275.0 0.590 0.647 0.875
FLI 1.4 (0.6) 1.2 (0.5) −14.3 0.040 1.6 (0.7) 1.3 (0.7) −18.8 0.006 0.331 0.047
FIB-4 0.8 (0.2) 0.8 (0.2) −2.5 0.452 1.2 (2.0) 0.7 (0.3) −41.7 0.207 0.418 0.495

Data are presented as the mean (SD). AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; NAFLD-FLS, Nonalcoholic Fatty Liver Disease Liver Fat Score; FLI, Fatty Liver Index; FIB-4, Fibrosis Index Based On Four Factors. aComparison within dietary groups (baseline and after 6 months). bBaseline differences between the AID and CD groups. cDifferences after 6 months between the AID and CD groups.